Industry Webcast
Improve Glycemic Control: The Role of Once-Daily GLP-1 RAs in T2DIndustry Webcast Sponsored by Novo Nordisk; Not for CME/CE Credit
In this interactive experience, you will explore the clinical profile, efficacy, and safety of a once-daily GLP-1 RA treatment for adults with T2D on your own phone or device. Lead your team to victory as you collect data blocks to evaluate mean change in glycated hemoglobin (A1C) results from a monotherapy trial in adult patients with T2D and evaluate proper administration and storage instructions. Finally, review dosing instructions to better understand scenarios for your appropriate adult patients with type 2 diabetes.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 10/23/2024
Expiration Date: 10/24/2024
Topics
Faculty
Faculty
Steve Vacalis, DO
Senior Lead Physician, CaroMont Family Medicine,
CaroMont Regional Medical Center
Gastonia, North Carolina
Supporters and Partners
Industry Sponsor
Novo Nordisk
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.